about
Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE).Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study resultsRisperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.A review of paliperidone palmitate.New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia.Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Long-acting injectable risperidone.
@ast
Long-acting injectable risperidone.
@en
type
label
Long-acting injectable risperidone.
@ast
Long-acting injectable risperidone.
@en
prefLabel
Long-acting injectable risperidone.
@ast
Long-acting injectable risperidone.
@en
P2860
P356
P1476
Long-acting injectable risperidone.
@en
P2093
Matthew A Fuller
Megan J Ehret
P2860
P304
P356
10.1345/APH.1E085
P407
P577
2004-11-02T00:00:00Z